Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3 ‐MAML2 fusions

ConclusionAn excellent prognosis may be achieved without PORT in T1/2N0M0 mucoepidermoid carcinoma patients positive forCRTC1/3 ‐MAML2 fusions when the tumors are completely resected without tumor spillage.

Source: Head and Neck - November 26, 2018 Category: ENT & OMF Authors: Yoshihide Okumura, Takayuki Murase, Kosuke Saida, Kana Fujii, Hisashi Takino, Ayako Masaki, Kei Ijichi, Kazuo Shimozato, Yuichiro Tada, Ken ‐ichi Nibu, Hiroshi Inagaki Tags: ORIGINAL ARTICLE Source Type: research